AI Bias Analysis
4 models · Takes ~15 seconds
Much-awaited results at ASCO show that scientists have indeed found a way to drug a "greasy ball" involved in pancreatic cancer.
Source
Stat News
Opens original article in a new tab
(MedPage Today) -- CHICAGO -- RASolute 302 trial results were hailed as a game-changing breakthrough in the treatment of pancreatic cancer. The phase III study showed that second-line daraxonrasib, an investigational oral RAS(ON) multi-selective...
A lung cancer drug developed in China was a highlight of ASCO but doctors want to see follow-up in a more diverse population.
By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.
ASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.
